308 Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for melanoma

• Dirk Schadendorf,
• Mark Middleton,
• Jeffrey Weber,
• Delphine Hennicken,
• Paolo Ascierto,
• Andriy Moshyk,
• Roberto Zoffoli,
• Anne Pieters,
• Adenike Amadi,
• Katrin Kupas,
• Srividya Kotapati

Affiliations

Dirk Schadendorf

6 University Hospital Essen, Essen and German Cancer Consortium, Essen, Germany

Mark Middleton

2Churchill Hospital, Oxford, UK

Jeffrey Weber

Aff11 grid.170693.a000000012353285XH. Lee Moffitt Cancer Center Tampa FL USA

Delphine Hennicken

Aff37 grid.419971.3Bristol-Myers Squibb Princeton NJ USA

Paolo Ascierto

6Istituto Nazionale Tumori IRCCS ‘Fondazione G. Pascale’, Naples, Italy

Andriy Moshyk

3Bristol-Myers Squibb, Lawrenceville, NJ, USA

Roberto Zoffoli

4Bristol Myers Squibb, Braine l’Alleud, NJ, Belgium

Anne Pieters

4Bristol Myers Squibb, Braine l’Alleud, NJ, Belgium

Adenike Amadi

4Bristol Myers Squibb, Braine l’Alleud, NJ, Belgium

Katrin Kupas

4Bristol Myers Squibb, Braine l’Alleud, NJ, Belgium

Srividya Kotapati

4Bristol Myers Squibb, Braine l’Alleud, NJ, Belgium